Comparison of patients who relapsed after 12 months showed a trend for improved RFS in patients who were treated for the whole intended period compared to patients with a shorter treatment duration.
← all excerpts
Early termination does not negatively impact the outcome of adjuvant immunotherapy in melanoma.
1
—
—